Pliant Therapeutics Q2 EPS $(0.36) Misses $(0.34) Estimate
Pliant Therapeutics (NASDAQ: PLRX ) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.34) by 5.88 percent. This is a 49.3 percent increase over losses of $(0.71) per share from the same period last year.